These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 15613544)

  • 1. CD38 and CD100 lead a network of surface receptors relaying positive signals for B-CLL growth and survival.
    Deaglio S; Vaisitti T; Bergui L; Bonello L; Horenstein AL; Tamagnone L; Boumsell L; Malavasi F
    Blood; 2005 Apr; 105(8):3042-50. PubMed ID: 15613544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-tandem insight from basic science combined with clinical research: CD38 as both marker and key component of the pathogenetic network underlying chronic lymphocytic leukemia.
    Deaglio S; Vaisitti T; Aydin S; Ferrero E; Malavasi F
    Blood; 2006 Aug; 108(4):1135-44. PubMed ID: 16621959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD100/Plexin-B1 interactions sustain proliferation and survival of normal and leukemic CD5+ B lymphocytes.
    Granziero L; Circosta P; Scielzo C; Frisaldi E; Stella S; Geuna M; Giordano S; Ghia P; Caligaris-Cappio F
    Blood; 2003 Mar; 101(5):1962-9. PubMed ID: 12406905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells.
    Deaglio S; Capobianco A; Bergui L; Dürig J; Morabito F; Dührsen U; Malavasi F
    Blood; 2003 Sep; 102(6):2146-55. PubMed ID: 12763926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia.
    Ibrahim S; Jilani I; O'Brien S; Rogers A; Manshouri T; Giles F; Faderl S; Thomas D; Kantarjian H; Keating M; Albitar M
    Cancer; 2003 Apr; 97(8):1914-9. PubMed ID: 12673718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No convincing evidence for a role of CD31-CD38 interactions in the pathogenesis of chronic lymphocytic leukemia.
    Tonino SH; Spijker R; Luijks DM; van Oers MH; Kater AP
    Blood; 2008 Aug; 112(3):840-3. PubMed ID: 18519815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD38/CD31 interactions activate genetic pathways leading to proliferation and migration in chronic lymphocytic leukemia cells.
    Deaglio S; Aydin S; Grand MM; Vaisitti T; Bergui L; D'Arena G; Chiorino G; Malavasi F
    Mol Med; 2010 Mar; 16(3-4):87-91. PubMed ID: 19956559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD38 and ZAP-70 are functionally linked and mark CLL cells with high migratory potential.
    Deaglio S; Vaisitti T; Aydin S; Bergui L; D'Arena G; Bonello L; Omedé P; Scatolini M; Jaksic O; Chiorino G; Efremov D; Malavasi F
    Blood; 2007 Dec; 110(12):4012-21. PubMed ID: 17699742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival.
    Zucchetto A; Benedetti D; Tripodo C; Bomben R; Dal Bo M; Marconi D; Bossi F; Lorenzon D; Degan M; Rossi FM; Rossi D; Bulian P; Franco V; Del Poeta G; Deaglio S; Gaidano G; Tedesco F; Malavasi F; Gattei V
    Cancer Res; 2009 May; 69(9):4001-9. PubMed ID: 19383907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification improves the prognostic value of CD38 expression in B-cell chronic lymphocytic leukaemia.
    Mainou-Fowler T; Dignum H; Taylor PR; Dickinson AM; Saunders PW; Proctor SJ; Summerfield GP
    Br J Haematol; 2002 Sep; 118(3):755-61. PubMed ID: 12181042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD38 expression distinguishes two groups of B-cell chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis.
    Zupo S; Isnardi L; Megna M; Massara R; Malavasi F; Dono M; Cosulich E; Ferrarini M
    Blood; 1996 Aug; 88(4):1365-74. PubMed ID: 8695855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia.
    Lanham S; Hamblin T; Oscier D; Ibbotson R; Stevenson F; Packham G
    Blood; 2003 Feb; 101(3):1087-93. PubMed ID: 12393552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple metamorphoses of CD38 from prognostic marker to disease modifier to therapeutic target in chronic lymphocytic leukemia.
    Vaisitti T; Audrito V; Serra S; Bologna C; Arruga F; Brusa D; Buonincontri R; Gizdic B; Deaglio S
    Curr Top Med Chem; 2013; 13(23):2955-64. PubMed ID: 24171772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD38 expression correlates with adverse biological features and predicts poor clinical outcome in B-cell chronic lymphocytic leukemia.
    D'Arena G; Musto P; Cascavilla N; Dell'Olio M; Di Renzo N; Perla G; Savino L; Carotenuto M
    Leuk Lymphoma; 2001 Jun; 42(1-2):109-14. PubMed ID: 11699197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CLL B cells with a bimodal CD38 expression pattern: persistence of bimodal populations despite effective therapy for B-CLL.
    Pittner BT; Jelinek DF; Kay NE
    Leukemia; 2004 Jan; 18(1):180-2. PubMed ID: 14523466
    [No Abstract]   [Full Text] [Related]  

  • 16. Apoptosis or plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells induced by cross-linking of surface IgM or IgD.
    Zupo S; Massara R; Dono M; Rossi E; Malavasi F; Cosulich ME; Ferrarini M
    Blood; 2000 Feb; 95(4):1199-206. PubMed ID: 10666191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Requirement for CD100-CD72 interactions in fine-tuning of B-cell antigen receptor signaling and homeostatic maintenance of the B-cell compartment.
    Kumanogoh A; Shikina T; Watanabe C; Takegahara N; Suzuki K; Yamamoto M; Takamatsu H; Prasad DV; Mizui M; Toyofuku T; Tamura M; Watanabe D; Parnes JR; Kikutani H
    Int Immunol; 2005 Oct; 17(10):1277-82. PubMed ID: 16113236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome aberrations evaluated by comparative genomic hybridization in B-cell chronic lymphocytic leukemia: correlation with CD38 expression.
    Ottaggio L; Viaggi S; Zunino A; Zupo S; Rossi E; Spriano M; Abbondandolo A; Ferrarini M
    Haematologica; 2003 Jul; 88(7):769-77. PubMed ID: 12857555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD100 and plexins B2 and B1 mediate monocyte-endothelial cell adhesion and might take part in atherogenesis.
    Luque MC; Gutierrez PS; Debbas V; Kalil J; Stolf BS
    Mol Immunol; 2015 Oct; 67(2 Pt B):559-67. PubMed ID: 26275342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CD100-CD72 interaction: a novel mechanism of immune regulation.
    Kumanogoh A; Kikutani H
    Trends Immunol; 2001 Dec; 22(12):670-6. PubMed ID: 11738997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.